Novavax (United States)

Novavax (United States)

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novavax (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

80%


Total
Publications

313


Total Open
Publications

251


Total
Citations

13K


Open Access
Percentage

80%


Total
Publications

313


Total Open
Publications

251


Total
Citations

13K

Wikipedia

Website

download

Breakdown

19% 42% 16% 23%

Publisher Open

19%

Both

42%

Other Platform Open

16%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

52%OA Journal

OA Journal 52%

85

Hybrid 29%

47

No Guarantees 19%

30

Other Platform Open

Domain 84%

137

Institution 20%

33

Other Internet 10%

17

Public 4%

6

Preprint 3%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
137
DOI
Other Internet
17
Europe PMC
Domain
10
DANS - Data Archiving and Networked Services
Institution
8
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
5
Figshare
Public
5
Research Square
Preprint
4
University of Padua - Padua Research Archive
Institution
3
University of Nottingham - Repository@Nottingham
Institution
3
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
3
1 / 3

Data updated 18 August 2025

Share

Share

Share